Literature DB >> 17511499

Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups.

Michelle K Calabretta1, Amit Kumar, Alison M McDermott, Chengzhi Cai.   

Abstract

Poly(amidoamine) (PAMAM) dendrimer derivatives have been investigated for their biological applications, especially for delivery of drugs, including antimicrobial drugs to eukaryotic cells, but their effects on bacterial cells are largely unexplored. Herein we report that amino-terminated PAMAM dendrimers are highly toxic to the common Gram-negative pathogen Pseudomonas aeruginosa. The concentration that kills 50% of the bacteria (EC50) was in the range of approximately 0.9-1.5 microg/mL for the generation 5, amino-terminated dendrimers with or without partial (43%) coating of poly(ethylene glycol) (PEG). These EC50 values were lower than that ( approximately 1.9-2.8 microg/mL) for LL-37, a potent antimicrobial peptide expressed in a variety of epithelia. On the contrary, the dendrimers were far less toxic (EC50 > 21 microg/mL) to the Gram-positive pathogen Staphylococcus aureus than LL-37 (EC50 = approximately 1.9 microg/mL). In agreement with the previous studies on other cell types, the dendrimers were not cytotoxic to human corneal epithelial cells at the concentrations that were toxic to P. aeruginosa. Our findings indicate that amino-terminated PAMAM dendrimers and their partially PEG-coated derivatives possess attractive antimicrobial properties, particularly against Gram-negative bacteria, thus expanding the potential biological application of the dendrimers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511499      PMCID: PMC2430505          DOI: 10.1021/bm0701088

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  52 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Crystallization of antimicrobial pores in membranes: magainin and protegrin.

Authors:  L Yang; T M Weiss; R I Lehrer; H W Huang
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Hybrids of silver nanoparticles with amphiphilic hyperbranched macromolecules exhibiting antimicrobial properties.

Authors:  Cyril Aymonier; Ulf Schlotterbeck; Lydie Antonietti; Philipp Zacharias; Ralf Thomann; Joerg C Tiller; Stefan Mecking
Journal:  Chem Commun (Camb)       Date:  2002-12-21       Impact factor: 6.222

Review 4.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

5.  Synthesis, antimicrobial activity and structural studies of low molecular mass lysine dendrimers.

Authors:  Jolanta Janiszewska; Zofia Urbańczyk-Lipkowska
Journal:  Acta Biochim Pol       Date:  2006-02-23       Impact factor: 2.149

6.  Physicochemical and antimicrobial properties of boron-complexed polyglycerol-chitosan dendrimers.

Authors:  Alvaro Antonio Alencar de Queiroz; Gustavo Abel Abraham; Maria Aparecida Pires Camillo; Olga Zazuco Higa; Gerald Saraiva Silva; María del Mar Fernández; Julio San Román
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

7.  High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model.

Authors:  Z Y Zhang; B D Smith
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

8.  Penicillin V-conjugated PEG-PAMAM star polymers.

Authors:  Hu Yang; Stephanie T Lopina
Journal:  J Biomater Sci Polym Ed       Date:  2003       Impact factor: 3.517

9.  Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.

Authors:  Yunhao Gong; Barry Matthews; Dorothy Cheung; Teresa Tam; Izabelle Gadawski; Daniel Leung; George Holan; John Raff; Stephen Sacks
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

10.  Hyperbranched molecular structures with potential antiviral activity: derivatives of 5,6-dihydroxyindole-2-carboxylic Acid.

Authors:  Mario Sechi; Fabio Casu; Ilaria Campesi; Stefano Fiori; Alberto Mariani
Journal:  Molecules       Date:  2006-12-18       Impact factor: 4.411

View more
  34 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

2.  Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.

Authors:  Analette I Lopez; Rose Y Reins; Alison M McDermott; Barbara W Trautner; Chengzhi Cai
Journal:  Mol Biosyst       Date:  2009-07-03

3.  Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.

Authors:  Anupa R Menjoge; Raghavendra S Navath; Abbas Asad; Sujatha Kannan; Chong J Kim; Roberto Romero; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2010-03-25       Impact factor: 12.479

4.  Nitric Oxide-Releasing Cyclodextrins.

Authors:  Haibao Jin; Lei Yang; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

5.  Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Hui Dai; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2011-06-20       Impact factor: 4.939

6.  Carbon nanodots as molecular scaffolds for development of antimicrobial agents.

Authors:  Maria Ngu-Schwemlein; Suk Fun Chin; Ryan Hileman; Chris Drozdowski; Clint Upchurch; April Hargrove
Journal:  Bioorg Med Chem Lett       Date:  2016-02-18       Impact factor: 2.823

Review 7.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

8.  Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers.

Authors:  Bing Wang; Raghavendra S Navath; Anupa R Menjoge; Bindu Balakrishnan; Robert Bellair; Hui Dai; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

9.  Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents.

Authors:  Yuan Lu; Danielle L Slomberg; Anand Shah; Mark H Schoenfisch
Journal:  Biomacromolecules       Date:  2013-09-06       Impact factor: 6.988

10.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.